ZBH
NYSE HealthcareZimmer Biomet Holdings, Inc.
$99.40
-$0.64 (-0.64%)
Live quote
52w: $79.12 – $106.88
Loading chart…
P/E Ratio27.06
P/B Ratio1.51
EV/EBITDA—
Debt/Equity—
ROE5.59%
ROIC—
Revenue Growth7.20%
Gross Margin41.59%
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Own ZBH? Track it here.
Create a free account to add ZBH to a portfolio and watch your P/L update in real time.
Custom screens, valuation models and backtesting are coming to Pro.